TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
Recruiting · NCT07082803 · Registry updated 2026-09-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma | Recruiting | Phase 1 | 2026-09-04 | NCT07082803 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Treeline Biosciences, Inc. | 4 |
14 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| BC Cancer - Vancouver | Vancouver | Canada | 15 |
| Cabrini Health | Malvern | Australia | 9 |
| Hospital of the University of Pennsylvania | Philadelphia | United States | 142 |
| Linear Clinical Research | Perth | Australia | 12 |
| Macquarie University Hospital | Macquarie Park | Australia | 3 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Peter MacCallum Cancer Centre | Melbourne | Australia | 10 |
| Princess Alexandra Hospital | Woolloongabba | Australia | 106 |
| Scri Oncology Partners | Nashville | United States | 156 |
| Stanford Medicine Cancer Center | Palo Alto | United States | 1 |
| The START Center for Cancer Care - Midwest | Grand Rapids | United States | 2 |
| The University of Texas MD Anderson Cancer Center | Houston | United States | 207 |
| Washington University School of Medicine | St Louis | United States | 26 |
| Weill Cornell Medicine - New York Presbyterian Hospital | New York | United States | 6 |